Overall, DAT imaging remains a pivotal tool for elucidating presynaptic dopaminergic integrity, enabling clinicians and researchers to track disease progression and to differentiate Parkinson’s disease from other parkinsonian syndromes. This evidence concerns the gene SLC6A3 and Parkinson disease.